New injection could fight stubborn joint infections after knee surgery
Disease control
Recruiting now
This early-phase trial tests a new drug called TNP-2092, given as an injection into the knee joint, for people with infections after knee replacement surgery. The study includes 33 participants and compares the new drug to standard antibiotics. The main goal is to check safety an…
Phase: PHASE1, PHASE2 • Sponsor: TenNor Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC